Fagron NV: Karin de Jong joins the board of directors
17 Octubre 2016 - 12:05AM
Changes in composition of board
of directors of Fagron
Regulated information
Waregem (Belgium) / Rotterdam (The Netherlands), 17 October
2016
The board of directors of Fagron has, following
the advice of the nomination and remuneration committee, decided to
co-opt Ms Karin de Jong as executive director of Fagron. Karin de
Jong will replace Mr Jan Peeters who stepped-down as executive
director of Fagron during the annual shareholders meeting of 9 May
2016.
Robert Peek, chairman of the
board of directors: "Ms De Jong has shown a
great deal of expertise, dedication and commitment in the turbulent
period behind us. Especially during the refinancing process of
Fagron, she played a very important role. We wish her every success
in her new position as director and CFO of Fagron."
Fagron's board of directors has taken notice of the resignation of
Mr Filiep Balcaen and Ms Freya Loncin (permanent representative of
Aubisque BVBA) as non-executive directors of Fagron. In accordance
with article 15 of Fagron's articles of association, the remaining
directors decided to co-opt Mr Marc Janssens and Mr Marc Coucke
(permanent representative of Alychlo NV) with immediate effect as
new non-executive directors of Fagron.
The formal appointment of Ms De Jong, Mr Janssens and Mr Coucke
will be proposed to the next general shareholders meeting of
Fagron.
Karin de Jong (1979)
Karin de Jong is CFO of Fagron since May 2016. Karin
has been working for Fagron since 2008, where she started as
business controller. In 2013 she was appointed group controller.
After graduating in business administration, accounting and
control, Karin completed the post-graduate register controller
degree at Erasmus University in Rotterdam, the Netherlands.
Marc Janssens (1959)
Marc Janssens is director asset management and member
of the executive committee of Baltisse since 2015. Baltisse is the
family and investment office for Mr Filiep Balcaen's family. Marc
started working at Petercam (now DeGroof Petercam) in 1988. He
became a partner in 1996 and has been a member of the board of
directors of Petercam since 2011. From 1984 until 1988, he worked
as an economic writer at Belgian daily De Standaard. Marc obtained
a master's degree in economic sciences from the KU Leuven,
Belgium.
Marc Coucke (1965)
Marc Coucke is the founder of Omega Pharma. Following
the sale thereof, he invests via NV Alychlo, in which he serves as
chairman, in several listed and non-listed companies. Marc Coucke
graduated in pharmacy from the state university of Ghent and
obtained an MBA from the Vlerick Management School in Ghent,
Belgium.
In the event of differences between the English
translation and the Dutch original of this press release, the
latter prevails.
For more
information:
Constantijn van Rietschoten
Chief Marketing Officer
Tel. +31 6 53 69 15 85
constantijn.van.rietschoten@fagron.com
Fagron profile
Fagron is a leading global company active in pharmaceutical
compounding and focused on delivering tailored pharmaceutical care
to hospitals, pharmacies, clinics and patients in 32 countries
around the world.
The Belgian company Fagron NV is
located in Waregem and is listed on Euronext Brussels and Euronext
Amsterdam under the ticker symbol 'FAGR'. The operational
activities of Fagron are driven by the Dutch company Fagron BV. The
head office of Fagron BV is located in Rotterdam.
Please open the link below for the
press release:
Karin de Jong joins the board of
directors
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Fagron NV via Globenewswire
Wt Agricultu Ld (LSE:FAGR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Wt Agricultu Ld (LSE:FAGR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024